EP0564037B1 - Abrasion resistant stopper to prevent generation of particles by piercing - Google Patents

Abrasion resistant stopper to prevent generation of particles by piercing Download PDF

Info

Publication number
EP0564037B1
EP0564037B1 EP93200885A EP93200885A EP0564037B1 EP 0564037 B1 EP0564037 B1 EP 0564037B1 EP 93200885 A EP93200885 A EP 93200885A EP 93200885 A EP93200885 A EP 93200885A EP 0564037 B1 EP0564037 B1 EP 0564037B1
Authority
EP
European Patent Office
Prior art keywords
stopper
spike
abrasion
fluid
elastomeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP93200885A
Other languages
German (de)
French (fr)
Other versions
EP0564037A1 (en
Inventor
Richard T. c/o STERLING WINTHROP INC. Liebert
Neil H. Sterling Winthrop Inc. Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Publication of EP0564037A1 publication Critical patent/EP0564037A1/en
Application granted granted Critical
Publication of EP0564037B1 publication Critical patent/EP0564037B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00Closures not otherwise provided for
    • B65D51/002Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means

Definitions

  • This invention relates to a stopper for a container and, more particularly, to an improved stopper for a container of parenteral solutions which is suitable for infusion spike penetration without producing unacceptable amounts of particulate matter.
  • Stopper systems for vials, bottles and the like are made of materials that are resistant to chemicals and pharmaceuticals such as corrosive materials, reagents, parenteral solutions and solid formulations reconstitutable with a solvent prior to use.
  • the most commonly used stopper system for such products has been glass or plastic bottles and vials equipped with rubber stoppers made of elastomeric materials. The system appears to provide for good hermetical seal, safe storage and easy access to the content through the elastomeric stopper via the use of an infusion spike when withdrawal of the content is desired.
  • the elastomeric stopper used comprises an elastomeric base, such as natural or synthetic rubber and an inert coating covering at least some portions of the stopper.
  • the coating used heretofore includes chlorobutyl rubber, polymeric fluorocarbon resins such as polytetrafluoroethylene (TEFLON) and various thermoplastic films.
  • the coating is intended to insulate the elastomeric stopper base from the content of the container in order to prevent contact and possible chemical reactions therebetween.
  • untreated elastomeric stoppers offer a high degree of resistance against the exterior surface of the spike as the spike is being pushed into the penetration area.
  • stopper fragments are generated, they are the result of the elastomeric portion of the stopper being abraded off the upper surface of the stopper as it conforms to the shape of the penetrating spike. The fragments are then transported into the interior wall of the vial as the spike rolls and drags the fragments during penetration.
  • an abrasion resistant stopper for a medical vial containing a fluid therein, the stopper being adapted to be pierced by an infusion spike and comprising a stopper body of an elastomeric material having a head portion and a fluid contacting leg portion, said leg portion being adapted to be inserted into said medical vial to hermetically seal said fluid therein, said head portion having a bottom, fluid-contacting surface and a top having a central pierceable portion, said central portion having a spike-receiving surface.
  • Silicone lubricant applied to the top of the stopper body head portion provides abrasion resistance.
  • silicone does reduce particle generation from the spiking procedure it also increases the risk of product contamination from its own composition.
  • the present invention addresses the need to eliminate or at least greatly reduce the particle generation from surface erosion of the stopper during spike penetration.
  • the invention reduces the risk of the push-through and blow-out tendency by minimizing frictional drag and residual elastic tension during spike penetration.
  • the present invention is characterised in that said spike-receiving surface is coated with an abrasion resistant film, said film being adapted to conform to the edges of a hole created by an infusion spike upon said spike piercing the stopper and providing a barrier between the spike and the elastomeric material, thereby preventing mechanical contact between the spike and the elastomeric material and the consequent generation of elastomeric particles by abrasion, said abrasion-resistant film being selected from the group consisting of polystyrene, polyvinyl acetate, polyvinyl chloride, polyvinylidene chloride, copolymer of polyvinyl chloride and polyvinylidine chloride, polymethylene oxide, polyphenylene oxide, polyphenylene sulfone, polyethylene terephthalate, polycarbonate, copolyesters and polycaprolactam.
  • the top of the head portion has a region surrounding the coated central portion which is not coated.
  • the coating on the top surface of the stopper conforms to the deformation of the stopper caused by the spike penetration procedure. It appears that, upon piercing, the spike is not in contact with the elastomeric stopper body but only with the abrasion-resistant coating thereby circumventing abrasion and eliminating the formation of elastomeric particulate materials.
  • the present invention provides a method of preventing the generation of elastomeric particles by abrasion between an infusion spike and an abrasion resistant stopper as defined above, wherein during piercing of the stopper by the infusion spike the abrasion resistant film of the stopper provides a barrier between the infusion spike and the elastomeric material of the stopper thereby preventing mechanical contact between the infusion spike and the elastomeric material and the consequent generation of elastomeric particles by abrasion.
  • numeral 10 shows one embodiment of the stopper of the present invention comprising: a head portion 20 and a leg portion 30.
  • Head portion 20 comprises a flange 22 which is adapted to cover a corresponding planar, circular mouth portion of a medical vial, while leg portion 30 is adapted for insertion into the neck of the vial to tightly seal the content therein.
  • Numeral 40 shows an abrasion-resistant film mounted on the centre part of the head portion 20 which serves as the piercing area for insertion and withdrawal of a spike.
  • numeral 10 shows another embodiment of the stopper of the present invention comprising: a head portion 20 and a leg portion 30.
  • Head portion 20 comprises a flange 22 which is adapted to cover a corresponding planar, circular mouth portion of a medical vial, while leg portion 30 is adapted for insertion into the neck of the vial to tightly seal the content therein.
  • Numeral 40 shows an abrasion-resistant film mounted on the top part of the head portion 20.
  • recess 32 extends toward the top surface of the head portion 20 forming a thin portion 34 in head portion 20 for facilitating piercing of the stopper by a spike.
  • FIG. 7 illustrates a stopper 10 having an abrasion-resistant film 40 covering vial 1.
  • Vial 1 containing an injectable fluid 5, is sealed by a stopper (which could be the stopper of FIGS. 1-3 or that of FIGS. 4-6) by inserting leg portion 30 of the stopper into the neck 7 of the vial 1.
  • Flange portion 22 of head portion 20 tightly seals the mouth 8 of vial 1.
  • a thin metal foil 9 is crimped over head portion 20 and flange portion 22 of the stopper to tightly seal and securely hold the stopper in vial 1.
  • the elastomeric material of the stopper body must be a fluid-impervious, resilient and inert material without leachable additives therein in order to prevent any alteration of the product contained in the vial. It may be of a single component or a blend of components.
  • the elastomeric material may be made into the desired stopper configuration by known methods. Such methods conventionally include the use of a curing agent, a stabilizer and a filler and comprise a primary and secondary curing step at elevated temperatures.
  • the abrasion-resistant coating for covering the top portion of the stopper, but at least the centre, pierceable portion thereof, may be: polystyrene, polyvinyl acetate (PVA), polyvinyl chloride (PVC), polyvinylidene chloride (PVDC), a copolymer of PVC and PVDC, polymethylene oxide, polyphenylene oxide, polyphenylene sulphone, polyethylene terephthalate (PET), polycarbonate, copolyesters and polycaprolactam (Nylon 6).
  • the coating thickness will be in the range of about 0.002 to 1.0 mm, and preferably about 0.02 to 0.5 mm.
  • the coating may be applied or bonded to the stopper body in any suitable manner known in the art, such as, but not limited to, by the use of adhesives, solvents, spray applications, radio waves, infrared, microwaves, ultrasonics and heat or a combination thereof.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Closures For Containers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Radiation-Therapy Devices (AREA)
  • Drilling Tools (AREA)
  • Polishing Bodies And Polishing Tools (AREA)
  • Heating, Cooling, Or Curing Plastics Or The Like In General (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Glass Compositions (AREA)
  • Tires In General (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Wrappers (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Arc Welding In General (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Passenger Equipment (AREA)

Abstract

An abrasion-resistant stopper (10) for a medical vial for containing a fluid therein comprising a stopper body of an elastomeric material having a head portion (20) and a fluid contactable leg portion (30), the leg portion (30) being adapted to be inserted into the medical vial for hermetically sealing the fluid therein and the head portion (20) comprising a top surface to receive a coating thereon, the top surface being coated with an abrasion-resistant coating (40) to prevent generation of particles upon piercing of the stopper (10) by a spike or a hypodermic needle. Preferably the coating (40) covers at least the centre, pierceable portion of the top surface and is advantageously polytetrafluoroethylene. <IMAGE>

Description

  • This invention relates to a stopper for a container and, more particularly, to an improved stopper for a container of parenteral solutions which is suitable for infusion spike penetration without producing unacceptable amounts of particulate matter.
  • Stopper systems for vials, bottles and the like are made of materials that are resistant to chemicals and pharmaceuticals such as corrosive materials, reagents, parenteral solutions and solid formulations reconstitutable with a solvent prior to use. The most commonly used stopper system for such products has been glass or plastic bottles and vials equipped with rubber stoppers made of elastomeric materials. The system appears to provide for good hermetical seal, safe storage and easy access to the content through the elastomeric stopper via the use of an infusion spike when withdrawal of the content is desired. The elastomeric stopper used comprises an elastomeric base, such as natural or synthetic rubber and an inert coating covering at least some portions of the stopper. The coating used heretofore includes chlorobutyl rubber, polymeric fluorocarbon resins such as polytetrafluoroethylene (TEFLON) and various thermoplastic films. The coating is intended to insulate the elastomeric stopper base from the content of the container in order to prevent contact and possible chemical reactions therebetween.
  • One of the major concerns in all products, and especially pharmaceutical parenteral products, is the generation of particulate foreign matter which may contaminate such products. In order to eliminate macroscopic and microscopic particulates, elaborate measures have been taken to remove them, such as filtration of the product and special washing and drying of the stopper system components. These steps help assure that the products meet the requirements and guidelines of the pharmaceutical industry, such as compendia guidelines, when the products reach the point of use. However, at the point of use, such as in the case of a parenteral product, new particulate matter is frequently generated by the practitioner when the stopper is penetrated by a spike of an infusion set or an infusion spike. During such penetration a combination of elastic and plastic deformation of the stopper target area increases the stopper contact surface with the infusion spike as it is pressed into the stopper. Typically, untreated elastomeric stoppers offer a high degree of resistance against the exterior surface of the spike as the spike is being pushed into the penetration area. Most frequently, when stopper fragments are generated, they are the result of the elastomeric portion of the stopper being abraded off the upper surface of the stopper as it conforms to the shape of the penetrating spike. The fragments are then transported into the interior wall of the vial as the spike rolls and drags the fragments during penetration.
  • In addition to the problem of particulate matter produced and carried into the vial during the spiking procedure, there are two other, although less frequently occurring, anomalies: stopper push-through into the vial and spike blow-out caused by residual elastic tension of the stopper against the spike which urges the spike outward.
  • The most common solution to these problems has been the application of silicone lubricant to the stopper and/or the spike to reduce the frictional drag between the stopper and the spike. It is thus known to provide an abrasion resistant stopper for a medical vial containing a fluid therein, the stopper being adapted to be pierced by an infusion spike and comprising a stopper body of an elastomeric material having a head portion and a fluid contacting leg portion, said leg portion being adapted to be inserted into said medical vial to hermetically seal said fluid therein, said head portion having a bottom, fluid-contacting surface and a top having a central pierceable portion, said central portion having a spike-receiving surface. Silicone lubricant applied to the top of the stopper body head portion provides abrasion resistance. However, while silicone does reduce particle generation from the spiking procedure it also increases the risk of product contamination from its own composition.
  • Another approach proposed in the prior art to reduce the tendency of the stopper to generate particulate matter during manufacturing and storage is to coat the elastomeric core of the stopper with a thermoplastic film on the fluid-contacting side thereof. We have found, however, that the use of such construction is less than satisfactory to solve the problem.
  • The present invention addresses the need to eliminate or at least greatly reduce the particle generation from surface erosion of the stopper during spike penetration. In addition, the invention reduces the risk of the push-through and blow-out tendency by minimizing frictional drag and residual elastic tension during spike penetration. These advantages are achieved without the use of a lubricant, such as silicone oil, which could contaminate the product contained in the vial or bottle.
  • We have found surprisingly that if a non-reactive, inert, coating which is highly resistant to abrasion is applied to the upper surface of an elastomeric stopper where spike penetration will take place, particle generation during spiking is all but eliminated and the tendency of push-through as well as blow-out of the spike is greatly reduced.
  • It is known from EP-A-0 294 127 to provide a fluorine resin film on the top of an elastomeric stopper, and from US-A-4 499 148 to provide a polyolefin film on the top of an elastomeric stopper. In both cases, the film is intended to reduce the occurrence of elastomeric particles due to a coring process when a hypodermic needle pierces the elastomer, resulting in the cutting out of a cylindrical elastomeric portion which may then undergo fragmentation into smaller pieces. The documents are not concerned with the problem of abrasion between the outer surface of an infusion spike and the surface of a hole which it creates.
  • Viewed from one aspect, the present invention is characterised in that said spike-receiving surface is coated with an abrasion resistant film, said film being adapted to conform to the edges of a hole created by an infusion spike upon said spike piercing the stopper and providing a barrier between the spike and the elastomeric material, thereby preventing mechanical contact between the spike and the elastomeric material and the consequent generation of elastomeric particles by abrasion, said abrasion-resistant film being selected from the group consisting of polystyrene, polyvinyl acetate, polyvinyl chloride, polyvinylidene chloride, copolymer of polyvinyl chloride and polyvinylidine chloride, polymethylene oxide, polyphenylene oxide, polyphenylene sulfone, polyethylene terephthalate, polycarbonate, copolyesters and polycaprolactam.
  • Preferably the top of the head portion has a region surrounding the coated central portion which is not coated.
  • In use, the coating on the top surface of the stopper conforms to the deformation of the stopper caused by the spike penetration procedure. It appears that, upon piercing, the spike is not in contact with the elastomeric stopper body but only with the abrasion-resistant coating thereby circumventing abrasion and eliminating the formation of elastomeric particulate materials.
  • Viewed from another aspect, therefore, the present invention provides a method of preventing the generation of elastomeric particles by abrasion between an infusion spike and an abrasion resistant stopper as defined above, wherein during piercing of the stopper by the infusion spike the abrasion resistant film of the stopper provides a barrier between the infusion spike and the elastomeric material of the stopper thereby preventing mechanical contact between the infusion spike and the elastomeric material and the consequent generation of elastomeric particles by abrasion.
  • Certain preferred embodiments of the invention will now be described by way of example and with reference to the following drawings in which
    • FIG. 1 is a perspective view of one embodiment of the stopper of the present invention;
    • FIG. 2 is a plan view of the stopper shown in FIG. 1;
    • FIG. 3 is a cross-sectional view of the stopper shown in FIG. 2 taken along the line a-a;
    • FIG. 4 is a perspective view of another embodiment of the stopper of the present invention;
    • FIG. 5 is a plan view of the stopper shown in FlG.4;
    • FIG. 6 is a cross-sectional view of the stopper shown in FIG. 2 taken-along the line b-b; and
    • FIG. 7 is a cross-section of a vial containing an injectable liquid closed with the stopper of the present invention.
  • Referring to FIGS. 1, 2 and 3, numeral 10 shows one embodiment of the stopper of the present invention comprising: a head portion 20 and a leg portion 30. Head portion 20 comprises a flange 22 which is adapted to cover a corresponding planar, circular mouth portion of a medical vial, while leg portion 30 is adapted for insertion into the neck of the vial to tightly seal the content therein. Numeral 40 shows an abrasion-resistant film mounted on the centre part of the head portion 20 which serves as the piercing area for insertion and withdrawal of a spike.
  • Referring to FIGS. 4, 5 and 6, numeral 10 shows another embodiment of the stopper of the present invention comprising: a head portion 20 and a leg portion 30. Head portion 20 comprises a flange 22 which is adapted to cover a corresponding planar, circular mouth portion of a medical vial, while leg portion 30 is adapted for insertion into the neck of the vial to tightly seal the content therein. Numeral 40 shows an abrasion-resistant film mounted on the top part of the head portion 20. In this embodiment recess 32 extends toward the top surface of the head portion 20 forming a thin portion 34 in head portion 20 for facilitating piercing of the stopper by a spike.
  • FIG. 7 illustrates a stopper 10 having an abrasion-resistant film 40 covering vial 1. Vial 1, containing an injectable fluid 5, is sealed by a stopper (which could be the stopper of FIGS. 1-3 or that of FIGS. 4-6) by inserting leg portion 30 of the stopper into the neck 7 of the vial 1. Flange portion 22 of head portion 20 tightly seals the mouth 8 of vial 1. A thin metal foil 9 is crimped over head portion 20 and flange portion 22 of the stopper to tightly seal and securely hold the stopper in vial 1.
  • The elastomeric material of the stopper body must be a fluid-impervious, resilient and inert material without leachable additives therein in order to prevent any alteration of the product contained in the vial. It may be of a single component or a blend of components.
  • The elastomeric material may be made into the desired stopper configuration by known methods. Such methods conventionally include the use of a curing agent, a stabilizer and a filler and comprise a primary and secondary curing step at elevated temperatures.
  • The abrasion-resistant coating for covering the top portion of the stopper, but at least the centre, pierceable portion thereof, may be: polystyrene, polyvinyl acetate (PVA), polyvinyl chloride (PVC), polyvinylidene chloride (PVDC), a copolymer of PVC and PVDC, polymethylene oxide, polyphenylene oxide, polyphenylene sulphone, polyethylene terephthalate (PET), polycarbonate, copolyesters and polycaprolactam (Nylon 6).
  • The coating thickness will be in the range of about 0.002 to 1.0 mm, and preferably about 0.02 to 0.5 mm. The coating may be applied or bonded to the stopper body in any suitable manner known in the art, such as, but not limited to, by the use of adhesives, solvents, spray applications, radio waves, infrared, microwaves, ultrasonics and heat or a combination thereof.
  • The present invention has been described in connection with the preferred embodiments shown in the drawings but is in no way limited thereto. It is to be noted that various changes and modifications of the invention as claimed are apparent to those skilled in the art.

Claims (3)

  1. An abrasion resistant stopper (10) for a medical vial (1) containing a fluid therein, the stopper being adapted to be pierced by an infusion spike and comprising a stopper body of an elastomeric material having a head portion (20) and a fluid contacting leg portion (30), said leg portion being adapted to be inserted into said medical vial to hermetically seal said fluid therein, said head portion having a bottom, fluid-contacting surface and a top having a central pierceable portion, said central portion having a spike-receiving surface, characterised in that said spike-receiving surface is coated with an abrasion resistant film (40), said film being adapted to conform to the edges of a hole created by an infusion spike upon said spike piercing the stopper and providing a barrier between the spike and the elastomeric material, thereby preventing mechanical contact between the spike and the elastomeric material and the consequent generation of elastomeric particles by abrasion, said abrasion-resistant film being selected from the group consisting of polystyrene, polyvinyl acetate, polyvinyl chloride, polyvinylidene chloride, copolymer of polyvinyl chloride and polyvinylidine chloride, polymethylene oxide, polyphenylene oxide, polyphenylene sulfone, polyethylene terephthalate, polycarbonate, copolyesters and polycaprolactam.
  2. An abrasion resistant stopper as claimed in claim 1, wherein the top of the head portion (20) has a region surrounding the coated central portion which is not coated.
  3. A method of preventing the generation of elastomeric particles by abrasion between an infusion spike and an abrasion resistant stopper (10) as claimed in claim 1 or 2, wherein during piercing of the stopper by the infusion spike the abrasion resistant film (40) of the stopper provides a barrier between the infusion spike and the elastomeric material of the stopper thereby preventing mechanical contact between the infusion spike and the elastomeric material and the consequent generation of elastomeric particles by abrasion.
EP93200885A 1992-04-02 1993-03-27 Abrasion resistant stopper to prevent generation of particles by piercing Expired - Lifetime EP0564037B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US862120 1986-05-12
US86212092A 1992-04-02 1992-04-02

Publications (2)

Publication Number Publication Date
EP0564037A1 EP0564037A1 (en) 1993-10-06
EP0564037B1 true EP0564037B1 (en) 1997-07-30

Family

ID=25337719

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93200885A Expired - Lifetime EP0564037B1 (en) 1992-04-02 1993-03-27 Abrasion resistant stopper to prevent generation of particles by piercing

Country Status (20)

Country Link
EP (1) EP0564037B1 (en)
JP (1) JPH0639017A (en)
KR (1) KR930021174A (en)
AT (1) ATE156088T1 (en)
AU (1) AU666910B2 (en)
BR (1) BR9301388A (en)
CA (1) CA2091020C (en)
CZ (1) CZ54393A3 (en)
DE (1) DE69312545T2 (en)
DK (1) DK0564037T3 (en)
ES (1) ES2108205T3 (en)
FI (1) FI931501A (en)
HU (1) HUT67955A (en)
IL (1) IL105247A (en)
MX (1) MX9301044A (en)
MY (1) MY131318A (en)
NO (1) NO931288L (en)
NZ (1) NZ247323A (en)
SK (1) SK27493A3 (en)
TW (1) TW227523B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6386392B1 (en) 1999-11-02 2002-05-14 The Procter & Gamble Company Reservoirs for use with cleaning devices
EP1078880B1 (en) 1999-08-05 2003-03-19 The Procter & Gamble Company Dispensing device comprising a reservoir and attachment means provided with protected piercing means
US6321941B1 (en) 2000-04-20 2001-11-27 The Procter & Gamble Company Consumer safe fitment for connecting a reservoir to a dispensing appliance
JP4601127B2 (en) * 2000-06-06 2010-12-22 住友ゴム工業株式会社 Medical rubber stopper
TWI303565B (en) 2002-08-16 2008-12-01 Glaxosmithkline Biolog Sa Closure system,vial having the closure system,method of closing a vial,method of filling a pharmaceutical vial, and vial closure
EP2546152A3 (en) 2002-09-03 2014-03-26 Medical Instill Technologies, Inc. Sealed containers and methods of making and filling same
US20090196798A1 (en) * 2008-02-06 2009-08-06 Robert Sassa Barrier with Low Extractables and Resealing Properties
CN102283776B (en) * 2011-07-07 2013-09-04 海南卫康制药(潜山)有限公司 Puncture-free bottle cork and application method thereof
DE102012101509A1 (en) * 2012-02-24 2013-08-29 Krones Aktiengesellschaft Pierceable plastic closure for sealing containers
USD713931S1 (en) 2013-01-09 2014-09-23 Central Garden & Pet Company Sprayer
CN113474083A (en) * 2019-01-04 2021-10-01 仪器实验室公司 Container stopper for high puncture count applications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3628681A (en) * 1969-10-06 1971-12-21 Plastics Consulting And Mfg Co Stopper
US4499148A (en) * 1983-01-10 1985-02-12 Canton Bio-Medical Products, Inc. Composite materials of silicone elastomers and polyolefin films, and method of making
JP2545540B2 (en) * 1987-05-29 1996-10-23 株式会社 大協精工 Double-sided laminated rubber stopper
DE8906346U1 (en) * 1989-05-23 1989-09-14 Pharma-Gummi Wimmer West Gmbh, 5180 Eschweiler Closure for medicine bottles

Also Published As

Publication number Publication date
IL105247A (en) 1997-04-15
TW227523B (en) 1994-08-01
BR9301388A (en) 1993-10-13
JPH0639017A (en) 1994-02-15
FI931501A0 (en) 1993-04-02
AU666910B2 (en) 1996-02-29
SK27493A3 (en) 1993-11-10
AU3280593A (en) 1993-10-07
NZ247323A (en) 1996-03-26
CZ54393A3 (en) 1995-11-15
MX9301044A (en) 1993-10-01
NO931288L (en) 1993-10-04
ES2108205T3 (en) 1997-12-16
HU9300971D0 (en) 1993-06-28
FI931501A (en) 1993-10-03
KR930021174A (en) 1993-11-22
HUT67955A (en) 1995-05-29
NO931288D0 (en) 1993-04-02
CA2091020A1 (en) 1993-10-03
EP0564037A1 (en) 1993-10-06
IL105247A0 (en) 1993-08-18
DE69312545D1 (en) 1997-09-04
ATE156088T1 (en) 1997-08-15
DE69312545T2 (en) 1998-02-19
DK0564037T3 (en) 1997-09-29
CA2091020C (en) 2005-01-25
MY131318A (en) 2007-08-30

Similar Documents

Publication Publication Date Title
US5219083A (en) Stopper for reduction of particulate matter
AU753628B2 (en) Closure system for containers
EP0573102B1 (en) Double-seal elastomeric stopper
EP0564037B1 (en) Abrasion resistant stopper to prevent generation of particles by piercing
US10246232B2 (en) Septa
EP0960616A2 (en) Multiple use universal stopper
EP1008337B1 (en) Medicament container closure with recessed integral spike access means
EP1221923B1 (en) Transfer set for vials and other medical containers
US7615271B2 (en) Method of fusing a component to a medical storage or transfer device and container assembly
EP0956849A2 (en) Universal stopper
EP0172613A2 (en) Resin-laminated rubber plug
US3198368A (en) Container closure
US5794804A (en) Pharmaceutical container with metal closures having reduced particulates
US6682518B1 (en) Injectable micro-glass vial
US6461345B1 (en) Cannula operated pinch valve

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17P Request for examination filed

Effective date: 19940316

17Q First examination report despatched

Effective date: 19950413

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NYCOMED IMAGING AS

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19970730

Ref country code: LI

Effective date: 19970730

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19970730

Ref country code: CH

Effective date: 19970730

Ref country code: BE

Effective date: 19970730

Ref country code: AT

Effective date: 19970730

REF Corresponds to:

Ref document number: 156088

Country of ref document: AT

Date of ref document: 19970815

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 69312545

Country of ref document: DE

Date of ref document: 19970904

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

ITF It: translation for a ep patent filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19971030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Effective date: 19971105

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2108205

Country of ref document: ES

Kind code of ref document: T3

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980331

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980930

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20120326

Year of fee payment: 20

Ref country code: FR

Payment date: 20120406

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20120326

Year of fee payment: 20

Ref country code: IT

Payment date: 20120327

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20120328

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 69312545

Country of ref document: DE

Representative=s name: J D REYNOLDS & CO., GB

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69312545

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20130326

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20130326

Ref country code: DE

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20130328

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20120326

Year of fee payment: 20

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20130705

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20130328

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20130327